UNK MAMMARY IMPLANT
Report
- Report Number
- 9617229-2021-06053
- Event Type
- Injury
- Date Received
- April 9, 2021
- Date of Event
- January 5, 2021
- Report Date
- April 9, 2021
- Manufacturer
- UNKNOWN MANUFACTURER
- Product Code
- FWM
- PMA / PMN Number
- P990074
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- PHYSICIAN
Narratives
ARTICLE CITATION: QUESADA, ANDRES E., ZHANG, YANMING, PTASHKIN, RYAN, ET AL. NEXT GENERATION SEQUENCING OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAS REVEALS A NOVEL STAT3-JAK2 FUSION AMONG OTHER ACTIVATING GENETIC ALTERATIONS WITHIN THE JAK-STAT PATHWAY. THE BREAST JOURNAL. 05/JAN/2021; 1-8. THE EVENTS OF LYMPHOMA - ALCL AND SEROMA - LATE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: BIA-ALCL; RIGHT BREAST SWELLING AND EFFUSION EIGHT YEARS AFTER IMPLANT.
THROUGH JOURNAL ARTICLE ¿NEXT GENERATION SEQUENCING OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAS REVEALS A NOVEL STAT3-JAK2 FUSION AMONG OTHER ACTIVATING GENETIC ALTERATIONS WITHIN THE JAK-STAT PATHWAY,¿ AUTHORS REPORT A (B)(6) PATIENT AND REASON FOR IMPLANT IS NOTED AS COSMETIC. PATIENT WAS IMPLANTED WITH A TEXTURED IMPLANT OF AN UNKNOWN FILL AND PRESENTED WITH RIGHT BREAST SWELLING AND EFFUSION EIGHT YEARS AFTER IMPLANT. THE STAGE OF ALCL WAS NOTED AS T1. TREATMENT PROVIDED AS BILATERAL COMPLETE CAPSULECTOMIES. THE MANUFACTURER OF THE DEVICE IS UNKNOWN. AFFECTED SIDE IS RIGHT. THE STATUS OF THE DEVICE IS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 539453 | UNK MAMMARY IMPLANT | PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE | FWM | UNKNOWN MANUFACTURER | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 35 YR | Life Threatening| R |